Gene amplifications in osteosarcoma -: CGH microarray analysis

被引:84
作者
Atiye, J
Wolf, M
Kaur, S
Monni, O
Böhling, T
Kivioja, A
Tas, É
Serra, M
Tarkkanen, M
Knuutila, S
机构
[1] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland
[2] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland
[3] Univ Helsinki, HUSLAB, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
[5] VTT Tech Res Ctr Finland, Turku, Finland
[6] Univ Turku, Turku, Finland
[7] Univ Helsinki, Biomedicum, Biochip Ctr, FIN-00014 Helsinki, Finland
[8] Univ Helsinki, Cent Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland
[9] Rizzoli Orthopaed Inst, Lab Oncol Res, Bologna, Italy
[10] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland
关键词
D O I
10.1002/gcc.20120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Little is known about the genomic alterations underlying osteosarcoma. We performed a genomewide high-resolution gene copy number analysis of 22 osteosarcoma samples using comparative genomic hybridization on a cDNA microarray that contained cDNA clones of about 13,000 genes. Nineteen of the 22 cases had amplifications that on average spanned more than 1 Mb and contained more than 10 genes. Numerous regions of gain and loss were identified, and their boundaries were defined at high resolution. Novel amplicons were found at 14q11, 17q25, and 22q11-q13. Earlier-known large amplified regions were detected at 12q11-q15, 8q24, 6p12-p13, and 17p1-p13 in 8, 6, 5, and 4 of the 22 samples, respectively. Amplification of 12q was observed more frequently (36% of the cases) than previously reported. Previously known small amplicons at 1p34-p36, 1q21, 19q13, and 21q22 were seen in at least three cases. Our results implicate TOM1L2 and CYP27B1 as having roles as novel targets for the 17p and 12q amplicons, respectively. Details (www.helsinki.fi/cmg) of the amplified genes in each amplicon provide valuable raw data for further in silico studies. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 22 条
[1]   Current treatment of high grade osteosarcoma of the extremity: Review [J].
Bacci, G ;
Lari, S .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (03) :235-243
[2]   Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma [J].
Dhaini, HR ;
Thomas, DG ;
Giordano, TJ ;
Johnson, TD ;
Biermann, JS ;
Leu, K ;
Hollenberg, PF ;
Baker, LH .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2481-2485
[3]  
El-Rifai W, 1997, LAB INVEST, V77, P699
[4]   Differentially amplified in low- and high-grade chromosome 12 sequences osteosarcoma [J].
Gisselsson, D ;
Pålsson, E ;
Höglund, M ;
Domanski, H ;
Mertens, F ;
Pandis, N ;
Sciot, R ;
Dal Cin, P .
GENES CHROMOSOMES & CANCER, 2002, 33 (02) :133-140
[5]  
Hyman E, 2002, CANCER RES, V62, P6240
[6]   Online access to CGH data of DNA sequence copy number changes [J].
Knuutila, S ;
Autio, K ;
Aalto, Y .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) :689-689
[7]   Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21 [J].
Meza-Zepeda, LA ;
Forus, A ;
Lygren, B ;
Dahlberg, AB ;
Godager, LH ;
South, AP ;
Marenholz, I ;
Lioumi, M ;
Florenes, VA ;
Mælandsmo, GM ;
Serra, M ;
Mischke, D ;
Nizetic, D ;
Ragoussis, J ;
Tarkkanen, M ;
Nesland, JM ;
Knuutila, S ;
Myklebost, O .
ONCOGENE, 2002, 21 (14) :2261-2269
[8]   Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer [J].
Monni, O ;
Bärlund, M ;
Mousses, S ;
Kononen, J ;
Sauter, G ;
Heiskanen, M ;
Paavola, P ;
Avela, K ;
Chen, YD ;
Bittner, ML ;
Kallioniemi, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5711-5716
[9]   Genome-wide analysis of DNA copy-number changes using cDNA microarrays [J].
Pollack, JR ;
Perou, CM ;
Alizadeh, AA ;
Eisen, MB ;
Pergamenschikov, A ;
Williams, CF ;
Jeffrey, SS ;
Botstein, D ;
Brown, PO .
NATURE GENETICS, 1999, 23 (01) :41-46
[10]  
Raymond AK, 2002, WHO CLASSIFICATION T, P264